On July 15, 2021, the Indonesian Food and Drug Monitoring Agency (BPOM) finally granted the Emergency Use Authorization for Ivermectin as the therapeutic drug to cure the Covid-19.
This was due to the country’s “worst-case scenario” epidemic at the time according to officials. The number of cases were soaring in the country and the medical authorities were desperate to control the outbreak.
Indonesia experienced a spike in COVID-19 infection and deaths in July and was struggling to slow the virus transmission due to its large population. The country was one of the nations greatly affected during the COVID pandemic. Indonesia is ranked as the world’s fourth most populous country with 277 million people.
The Strait Times reported:
The Indonesian government on Thursday (July 15) began distributing free medicine and vitamins to self-isolating Covid-19 patients in high-risk areas as the highly transmissible Delta variant of the coronavirus continued to rip through the country, emptying pharmacy shelves.
Each package will have seven days worth of therapeutic Covid-19 drugs and vitamins, and will be given to asymptomatic patients as well as those with mild to moderate symptoms including fever and dry cough. The medication for the latter group will require consultation with a doctor and a prescription.
Medical facilities are stretched thin, and demand for oxygen and medication has also soared. As scores of people are isolating themselves at home and self-medicating, prices of drugs have shot up in pharmacies and online. The health ministry has since moved to cap the prices of drugs such as favipiravir, remdesivir and ivermectin.
After the government authorized the use of Ivermectin for COVID-19 patients and its population, the number of cases have significantly plummeted since July.
The data above proves that Ivermectin played a role in the steep decline of COVID-19 cases. This is obvious despite the claim from fact-checker website below that there is “no evidence that the fall in COVID-19 cases in Indonesia is linked to the use of Ivermectin.”